Aeglea BioTherapeutics
leverages genetically driven patient selection to match disease drivers with therapeutic targets | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
12 of 56
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
September 2023
leverages genetically driven patient selection to match disease drivers with therapeutic targets | Aeglea BioTherapeutics
Mergers and Acquisitions
June 2023
leverages genetically driven patient selection to match disease drivers with therapeutic targets | Aeglea BioTherapeutics
Related slides by other companies
Fusion Pharmaceuticals
Investor Presentation
January 2024
program milestones patients | Fusion Pharmaceuticals
9 Meters Biopharma
Investor Presentation
September 2022
study demographics patient phenotype meters | 9 Meters Biopharma
Theravance Biopharma
Investor Conference
November 2022
new study in patients with cypress | Theravance Biopharma
NeuroSense Therapeutics
Investor Presentation
January 2024
randomized prospective double blind placebo controlled study phase design placebo controlled road | NeuroSense Therapeutics
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Mergers and Acquisitions
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io